CSIMarket
 
Allakos Inc   (ALLK)
 

News about Allakos Inc




Lirentelimab Trials in Atopic Dermatitis and Chronic Spontaneous Urticaria Fail to Meet Primary Endpoints: Implications for Allakos* Future Development
Jan 16 2024
In recent years, the field of pharmaceutical sciences has witnessed tremendous progress in the development of novel therapeutics. One such promising c...

Major Pharmaceutical Preparations Company, Allakos Inc., Reports Significant Reduction in Financial Performance during the Third Quarter of 2023
Nov 14 2023
As the reporting season for July to September 30, 2023 continues, several businesses from various industries have released their financial n...

Allakos Inc, a Major Pharmaceutical Preparations industry player, reports significant improvement in Q2 2023 with operating deficit reducing to $-49.117 million, showing economic enhancement despite challenging sector standards
Aug 11 2023
Allakos Inc, a lesser-known player in the Major Pharmaceutical Preparations sector, recently reported its earnings for the second quarter of 2023. The...

ALLK Announces Improved First Quarter 2023 Performance Amidst Challenging Market
May 11 2023
Allakos Inc. is a leading company in the pharmaceutical preparations industry. The San Carlos-based firm specializes in the development of therapeutic...

Allakos Inc declared operating loss in the fourth quarter of 2022
May 11 2023
...

The company caused some good surprise for the shareholders, posting a relevant gain in most recent fiscal period with operating shortfall of $-31.445 millions
May 11 2023
...









Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com